ICF International, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ICF International, Inc. on November 8, 2021. The filing reports a corporate governance event regarding the expansion of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition changes and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from eight (8) to nine (9) members.
- New Appointment: Dr. Michelle Williams was appointed to the Board, effective December 1, 2021.
- Committee Assignment: Dr. Williams has been designated as a member of the Audit Committee.
- Term: She will serve as a Class II director until the 2023 annual meeting of stockholders.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The document highlights Dr. Williams' background as a renowned epidemiologist and public health scientist, currently serving as Dean of Faculty at Harvard T.H. Chan School of Public Health and Harvard Kennedy School. She will receive the standard director's compensation package for 2021 applicable to non-employee directors.
Investor Verification Checklist
- Verify the effective date of Dr. Williams' appointment (December 1, 2021).
- Confirm the new total size of the Board of Directors (9 members).
- Review the attached press release (Exhibit 99.1) for additional details on the appointment.
- Check subsequent filings for any changes to the Audit Committee composition.